🟢 Wave Life Sciences is trading 5% up in pre-market; UBS initiation may be a catalyst

Wave Life Sciences is trading 5.18% higher at $3.25 in pre-market on October 15, 2026; UBS’s recent initiation is a possible, unconfirmed catalyst.

• UBS initiated coverage with a Buy rating and an $11 price target on October 14.
• No new major company announcement explaining the rise was identified for October 15. Inflation concerns are weighing on technology shares amid a broader risk-off backdrop.